NASDAQ:IMVT | Income Statement | Immunovant, Inc.

Complete source-backed income-statement history.

Available history
2018-06-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$160.32M-$153.22M$0.00-$153.22M-$0.75-$0.75205,545,373205,545,373
2026-03-31$159.55M-$150.7M-$2.84M-$147.86M-$0.73-$0.737,006,7427,006,742
2025-12-31$114.36M-$109.08M$1.55M-$110.64M-$0.61-$0.61181,513,386181,513,386
2025-09-30$131.76M-$125.91M$594,000.00-$126.5M-$0.73-$0.73173,643,829173,643,829
2025-06-30$127.22M-$119.7M$913,000.00-$120.61M-$0.71-$0.71170,872,994170,872,994
2025-03-31$113.83M-$105.87M$583,000.00-$106.45M-$0.63-$0.635,013,1395,013,139
2024-12-31$114.3M-$110.97M$152,000.00-$111.12M-$0.76-$0.76146,922,338146,922,338
2024-09-30$115.74M-$109.04M$78,000.00-$109.12M-$0.74-$0.74146,468,991146,468,991
2024-06-30$94.28M-$87.07M$77,000.00-$87.15M-$0.60-$0.60146,085,729146,085,729
2024-03-31$80.88M-$75.09M$232,000.00-$75.32M-$0.52-$0.522,523,3102,523,310
2023-12-31$61.55M-$51.53M-$108,000.00-$51.42M-$0.36-$0.36144,523,034144,523,034
2023-09-30$61.8M-$58.21M$454,000.00-$58.66M-$0.45-$0.45131,155,642131,155,642
2023-06-30$78.48M-$73.95M-$11,000.00-$73.94M-$0.57-$0.57130,503,264130,503,264
2023-03-31$64.26M-$60.42M-$991,000.00-$59.43M-$0.45-$0.452,410,0302,410,030
2022-12-31$64.03M-$62.84M$387,000.00-$63.23M-$0.49-$0.49128,574,190128,574,190
2022-09-30$37.74M$49.61M-$47.67M$261,000.00-$47.93M-$0.41-$0.41116,572,820116,572,820
2022-06-30$28.43M$40.38M-$40.02M$352,000.00-$40.37M-$0.35-$0.35116,557,508116,557,508
2022-03-31$31.99M$47.23M-$47.18M-$12,000.00-$47.17M-$0.41-$0.412,231,5112,231,511
2021-12-31$29.76M$41.27M-$41.39M$0.00-$41.39M-$0.36-$0.36115,025,191115,025,191
2021-09-30$21.36M$37.65M-$37.73M-$31,000.00-$37.7M-$0.35-$0.35109,078,427109,078,427
2021-06-30$18.71M$29.89M-$30.51M-$41,000.00-$30.47M-$0.31-$0.3197,976,98297,976,982
2021-03-31$18.62M$28.92M-$28.24M-$79,000.00-$28.16M-$0.28-$0.283,343,0023,343,002
2020-12-31$21.09M$31.64M-$32.14M-$367,000.00-$31.78M-$0.32-$0.3297,920,46097,920,460
2020-09-30$11.98M$20.97M-$20.75M$40,000.00-$20.79M-$0.25-$0.2584,353,43884,353,438
2020-06-30$16.92M$26.59M-$26.66M$48,000.00-$26.71M-$0.38-$0.3870,818,86770,818,867
2020-03-31$14.17M$20.48M-$20.61M-$59,000.00-$20.55M3,790,955
2019-12-31$4.95M$11.04M-$11.2M$100,000.00-$11.3M41,035,055
2019-09-30$10.33M$14.49M-$419,757.00-$14.45M$33,000.00-$14.48M38,590,381
2019-06-30$18.48M$20.06M-$92,342.00-$20.04M$23,000.00-$20.06M38,590,381
2019-03-31$7.97M$8.93M-$9.03M$7,000.00-$9.03M5,355,135
2018-12-31$7.68M$8.88M-$8.84M$8,000.00-$8.85M36,735,341
2018-09-30-$6.35M
2018-06-30-$4.37M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-03-31$532.9M-$505.39M$215,000.00-$505.61M-$2.77-$2.77182,421,233182,421,233
2025-03-31$438.15M-$412.95M$891,000.00-$413.84M-$2.73-$2.73151,573,553151,573,553
2024-03-31$282.71M-$258.77M$567,000.00-$259.34M-$1.88-$1.88138,100,577138,100,577
2023-03-31$218.28M-$210.95M$9,000.00-$210.96M-$1.71-$1.71123,075,329123,075,329
2022-03-31$101.81M$156.03M-$156.81M-$84,000.00-$156.73M-$1.43-$1.43109,679,256109,679,256
2021-03-31$68.6M$108.12M-$107.79M-$358,000.00-$107.43M-$1.22-$1.2287,756,51387,756,513
2020-03-31$47.93M$66.08M-$66.29M$97,000.00-$66.39M43,199,191
2019-03-31$25.73M$28.43M-$28.58M$19,000.00-$28.6M22,170,862